Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

JOHNSON & JOHNSON

(JNJ)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Coronavirus-Mozambique: The United States Donates Additional 2 Million Johnson & Johnson Vaccines to Mozambique The United States remains committed to sharing vaccines equitably, around the world

12/06/2021 | 02:41pm EST

The U.S. Embassy in Mozambique announces the arrival of 2,016,000 doses of the Johnson & Johnson vaccine that the United States is sharing with the Republic of Mozambique through COVAX. This is the United States’ fourth and largest bi-lateral COVID-19 vaccine delivery to Mozambique, bringing the total number of U.S.-donated vaccines to nearly 3.5 million, and maintaining the United States as Mozambique’s largest bi-lateral vaccine donor.

"The United States remains committed to sharing vaccines equitably, around the world," U.S. Ambassador to Mozambique Dennis W. Hearne said. "No one is protected from COVID-19 until everyone is vaccinated. As more vaccines become available to all nations around the world, we have a shared interest in getting everyone who is eligible vaccinated."

The U.S. Government has provided early and ongoing support for the response to the COVID-19 pandemic in Mozambique, including assistance valued at $62.5 million. This assistance includes the recent donation of 60 oxygen cylinders and a PSA oxygen plant, 50 ventilators, personal protective equipment for healthcare workers, laboratory and oxygen equipment, training, and funding for increased medical staff, among other initiatives. For more information on U.S. support for Mozambique’s efforts to combat COVID-19, visit thislink.

In close collaboration with the Government of the Republic of Mozambique, the U.S. Government provides more than $500 million in annual assistance to improve the quality of education and healthcare, promote economic prosperity, and support the overall development of the nation.


Distributed by APO Group on behalf of U.S. Embassy in Mozambique.

© African Press Organization, source Press Releases

All news about JOHNSON & JOHNSON
05:30pJohnson & Johnson to Participate in Citi's 2022 Virtual Healthcare Conference
PR
03:44pHealth Care Outperform Amid Fading Thursday Markets
MT
01:24pHealth Care Stocks Still Outperforming Amid Fading Thursday Markets
MT
12:38pGalapagos Names Former Johnson & Johnson Executive Paul Stoffels CEO; Shares Soar
MT
10:33aMeiraGTx Gets $30 Million Milestone Payment from Janssen Pharmaceuticals for Retinitis ..
MT
08:53aMeiraGTx Gets $30 Million Milestone Payment From Janssen Pharmaceuticals
DJ
08:09aJOHNSON & JOHNSON : Marks More Than 2 Billion Doses of Medicine Donated to Date to Help Co..
PU
05:36aDA Davidson Lifts Johnson & Johnson's Price Target to $196 From $188, Citing 'Increased..
MT
01/26Galapagos Appoints Former Johnson & Johnson Exec to Succeed Retiring CEO
MT
01/26Drugmaker Galapagos names former J&J exec Paul Stoffels as CEO
RE
More news
Analyst Recommendations on JOHNSON & JOHNSON
More recommendations
Financials (USD)
Sales 2021 94 304 M - -
Net income 2021 22 542 M - -
Net cash 2021 815 M - -
P/E ratio 2021 20,3x
Yield 2021 2,44%
Capitalization 449 B 449 B -
EV / Sales 2021 4,75x
EV / Sales 2022 4,38x
Nbr of Employees 134 500
Free-Float 84,3%
Chart JOHNSON & JOHNSON
Duration : Period :
Johnson & Johnson Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends JOHNSON & JOHNSON
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Last Close Price 170,59 $
Average target price 183,33 $
Spread / Average Target 7,47%
EPS Revisions
Managers and Directors
Joaquin Duato Chief Executive Officer & Director
Joseph J. Wolk Chief Financial Officer & Executive Vice President
Alex Gorsky Executive Chairman
James D. Swanson Global Chief Information Officer & Executive VP
Charles O. Prince Independent Director
Sector and Competitors
1st jan.Capi. (M$)
JOHNSON & JOHNSON-1.57%443 277
ROCHE HOLDING AG-7.91%306 143
PFIZER, INC.-10.23%297 538
ABBVIE INC.-0.86%237 303
ELI LILLY AND COMPANY-13.89%215 642
NOVO NORDISK A/S-15.89%213 450